Blink Triple Care Solution/ Drops
NDC Package 29943-006-10
Package Information
Blink Triple Care (polyethylene glycol 400) solution/ dropses is shake well before use.Instill 1 or 2 drops in the affected eye(s) as needed or as directed by your eye care professional. This formulation utilizes a solution/ drops delivery system. Marketed by Bausch & Lomb Incorporated, this product is identified by NDC 29943-006 and is authorized under FDA application M018.
Identification & Billing
- RxCUI: 1094102 - blink Tears 0.25 % Ophthalmic Solution
- RxCUI: 1094102 - polyethylene glycol 400 2.5 MG/ML Ophthalmic Solution [Blink Tears]
- RxCUI: 1094102 - Blink Tears 0.25 % Lubricating Eye Drops
- RxCUI: 1094102 - Blink Tears 2.5 MG/ML Ophthalmic Solution
- RxCUI: 853238 - polyethylene glycol 400 0.25 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 29943 - Bausch & Lomb Incorporated
- 29943-006 - Blink Triple Care
- 29943-006-10 - 10 mL in 1 BOTTLE, DROPPER
- 29943-006 - Blink Triple Care
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (29943-006). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 29943-006-10 identifies a specific commercial package of 10 ml in 1 bottle, dropper of Blink Triple Care, a human over the counter drug labeled by Bausch & Lomb Incorporated. This product is billed per "ML" milliliter and contains an estimated amount of 10 billable units per package. This solution/ drops is formulated for ophthalmic use and contains polyethylene glycol 400 as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch & Lomb Incorporated on May 01, 2022. The current certification is valid through December 31, 2027.
How is this Bausch & Lomb Incorporated product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 29943000610. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.